Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.33 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.33 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.33 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.31 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.31 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cysteine SCHEMBL359120 | 1.00 | PTGS1 (0.50) | PTGS1SLC7A11HDAC3HDAC4HDAC1 | |
| SCHEMBL359121 | 0.76 | HDAC3 (0.32) | PTGS1SLC7A11HDAC3HDAC4HDAC1 | |
| Cysteine SCHEMBL1457838 | 0.73 | — | — | |
| Cysteine SCHEMBL28172831 | 0.73 | — | — | |
| Cysteine SCHEMBL28172077 | 0.71 | — | — | |
| Cysteine SCHEMBL7898895 | 0.71 | PTGS1 (1.00) | PTGS1SLC7A11GRIA1GRIA3ENPEP | |
| Cysteine SCHEMBL4289403 | 0.71 | — | — | |
| Cysteine SCHEMBL339562 | 0.71 | PTGS1 (1.00) | PTGS1SLC7A11GRIA1GRIA3ENPEP | |
| Cysteine SCHEMBL1868335 | 0.71 | PTGS1 (1.00) | PTGS1SLC7A11GRIA1GRIA3ENPEP | |
| Cysteine SCHEMBL21110883 | 0.71 | PTGS1 (1.00) | PTGS1SLC7A11GRIA1GRIA3ENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11992518-B2 | Molecular vaccines for infectious disease | AGILENT TECHNOLOGIES, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-10968269-B1 | MHC multimers in borrelia diagnostics and disease | AGILENT TECHNOLOGIES, INC. (US) | 2021-04-06 | — | — | US | disclosed |
| US-20210047383-A1 | MHC Multimers in Borrelia Diagnostics and Disease | DAKO DENMARK APS (DK) | 2021-02-18 | — | — | US | disclosed |
| US-20200347103-A1 | MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS | AGILENT TECHNOLOGIES INC (US) | 2020-11-05 | — | — | US | disclosed |
| US-10611818-B2 | MHC multimers in tuberculosis diagnostics, vaccine and therapeutics | AGILENT TECHNOLOGIES, INC. (US) | 2020-04-07 | — | — | US | disclosed |
| US-20190314471-A1 | MOLECULAR VACCINES FOR INFECTIOUS DISEASE | AGILENT TECHNOLOGIES, INC. | 2019-10-17 | — | — | US | disclosed |
| US-10369204-B2 | Molecular vaccines for infectious disease | DAKO DENMARK A/S (DK) | 2019-08-06 | — | — | US | disclosed |
| US-20120258126-A1 | Molecular Vaccines for Infectious Disease | DAKO DENMARK A/S (DK) | 2012-10-11 | — | — | US | disclosed |
| US-20110318380-A1 | MHC Multimers in Cancer Vaccines and Immune Monitoring | DAKO DENMARK A/S (DK) | 2011-12-29 | — | — | US | disclosed |
| US-20110236411-A1 | MHC Multimers in Tuberculosis Diagnostics, Vaccine and Therapeutics | DAKO DENMARK A/S (DE) | 2011-09-29 | — | — | US | disclosed |
| EP-2337795-A2 | MHC MULTIMERS IN CANCER VACCINES AND IMMUNE MONITORING | Dako Denmark A/S (DK) | 2011-06-29 | — | — | EP | disclosed |
| EP-2254592-A2 | MHC MULTIMERS IN BORRELIA DIAGNOSTICS AND DISEASE | Dako Denmark A/S (DK) | 2010-12-01 | — | — | EP | disclosed |
| EP-2197908-A2 | MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS | Dako Denmark A/S (DK) | 2010-06-23 | — | — | EP | disclosed |
| WO-2010037402-A1 | MOLECULAR VACCINES FOR INFECTIOUS DISEASE | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | disclosed |
| WO-2010037395-A2 | MHC MULTIMERS IN CANCER VACCINES AND IMMUNE MONITORING | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | disclosed |
| WO-2010037397-A1 | MHC MULTIMERS IN CMV IMMUNE MONITORING | DAKO DENMARK A/S (DK) | 2010-04-08 | — | — | WO | disclosed |
| WO-2009106073-A2 | MHC MULTIMERS IN BORRELIA DIAGNOSTICS AND DISEASE | DAKO DENMARK A/S (DK) | 2009-09-03 | — | — | WO | disclosed |
| WO-2009039854-A2 | MHC MULTIMERS IN TUBERCULOSIS DIAGNOSTICS, VACCINE AND THERAPEUTICS | DAKO DENMARK A/S (DK) | 2009-04-02 | — | — | WO | disclosed |